102 related articles for article (PubMed ID: 17880609)
1. Complications of apheresis in children.
Michon B; Moghrabi A; Winikoff R; Barrette S; Bernstein ML; Champagne J; David M; Duval M; Hume HA; Robitaille N; Bélisle A; Champagne MA
Transfusion; 2007 Oct; 47(10):1837-42. PubMed ID: 17880609
[TBL] [Abstract][Full Text] [Related]
2. The world apheresis association registry, 2023 update.
Vrielink H; Le Poole K; Stegmayr B; Kielstein J; Berlin G; Ilhan O; Seval GC; Prophet H; Aandahl A; Deeren D; Bojanic I; Blaha M; Lanska M; Gasova Z; Bhuiyan-Ludvikova Z; Blahutova S; Hrdlickova R; Audzijoniene J; Griskevicius A; Glatt T; Strineholm V; Ott M; Nilsson T; Newman E; Derfler K; Witt V; Toss F
Transfus Apher Sci; 2023 Dec; 62(6):103831. PubMed ID: 37827962
[TBL] [Abstract][Full Text] [Related]
3. The Italian registry of therapeutic apheresis in SISTRA: Year of activity 2022.
De Silvestro G; Catalano L; Marano G; Piccinini V; Pupella S; Ostuni A; De Angelis V
Transfus Apher Sci; 2024 Feb; 63(1):103863. PubMed ID: 38065773
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation.
Okwuonu CG; Shah M; Rafique I; Abdelrazeq AS; Dumor K; Balogun RA
Ther Apher Dial; 2024 Jun; ():. PubMed ID: 38828528
[TBL] [Abstract][Full Text] [Related]
5. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
Loirat C; Fakhouri F; Ariceta G; Besbas N; Bitzan M; Bjerre A; Coppo R; Emma F; Johnson S; Karpman D; Landau D; Langman CB; Lapeyraque AL; Licht C; Nester C; Pecoraro C; Riedl M; van de Kar NC; Van de Walle J; Vivarelli M; Frémeaux-Bacchi V;
Pediatr Nephrol; 2016 Jan; 31(1):15-39. PubMed ID: 25859752
[TBL] [Abstract][Full Text] [Related]
6. Complications of therapeutic apheresis in children.
Kara A; Turgut S; Cağlı A; Sahin F; Oran E; Tunç B
Transfus Apher Sci; 2013 Jun; 48(3):375-6. PubMed ID: 23685078
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic apheresis: is it safe in children with kidney disease?
Kalenderoğlu MD; Çomak E; Aksoy GK; Bilge U; Küpesiz OA; Koyun M; Akman S
Pediatr Nephrol; 2024 Aug; 39(8):2451-2457. PubMed ID: 38502222
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange in paediatric nephrology in Ireland.
Wildes DM; Devlin C; Costigan CS; Raftery T; Hensey C; Waldron M; Dolan N; Riordan M; Sweeney C; Stack M; Cotter M; Lynch B; Gorman KM; Awan A
Ir J Med Sci; 2024 Jun; 193(3):1589-1594. PubMed ID: 37940814
[TBL] [Abstract][Full Text] [Related]
9. Comparative study between chronic automated red blood cell exchange and manual exchange transfusion in patients with sickle cell disease: A single center experience from Saudi Arabia.
Al Mozain N; Elobied Y; Al-Omran A; Aljaloud A; Omair AB; Tuwaim RB; Alkhalifah S; Altawil ES; Abraham S; Salcedo LR; Parena A; Shah F; Ayyoubi MT; Hermelin D; Al Gahtani F; Alfeky MA; El Gohary G
Asian J Transfus Sci; 2023; 17(1):91-96. PubMed ID: 37188028
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in microfluidic cell separation to enable centrifugation-free, low extracorporeal volume leukapheresis in pediatric patients.
Iqbal M; Mukhamedshin A; Lezzar DL; Abhishek K; McLennan AL; Lam FW; Shevkoplyas SS
Blood Transfus; 2023 Nov; 21(6):494-513. PubMed ID: 37146298
[TBL] [Abstract][Full Text] [Related]
11. Atypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Plasma Exchange and Eculizumab.
Kannan L
Am J Case Rep; 2023 Apr; 24():e938896. PubMed ID: 37120715
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput microfluidic device based on controlled incremental filtration to enable centrifugation-free, low extracorporeal volume leukapheresis.
Lezzar DL; Lam FW; Huerta R; Mukhamedshin A; Lu M; Shevkoplyas SS
Sci Rep; 2022 Aug; 12(1):13798. PubMed ID: 35963876
[TBL] [Abstract][Full Text] [Related]
13. Multiple Sclerosis: Therapeutic Strategies on the Horizon.
Talanki Manjunatha R; Habib S; Sangaraju SL; Yepez D; Grandes XA
Cureus; 2022 May; 14(5):e24895. PubMed ID: 35706718
[TBL] [Abstract][Full Text] [Related]
14. Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome.
Meregildo-Rodriguez ED; Bardales-Zuta VH
Infez Med; 2021; 29(4):589-599. PubMed ID: 35146369
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments.
Bertacchi M; Parvex P; Villard J
Clin Transplant; 2022 Apr; 36(4):e14608. PubMed ID: 35137982
[TBL] [Abstract][Full Text] [Related]
16. Role of therapeutic apheresis in the treatment of pediatric kidney diseases.
Shah S; Joseph C; Srivaths P
Pediatr Nephrol; 2022 Feb; 37(2):315-328. PubMed ID: 33991255
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Plasma Exchange Application in Children Requires Individual Decision.
Atay G; Demirkol D
J Pediatr Intensive Care; 2021 Jun; 10(2):106-109. PubMed ID: 33884210
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome.
Doxaki C; Papadopoulou E; Maniadaki I; Tsakalis NG; Palikaras K; Vorgia P
Front Pediatr; 2020; 8():608695. PubMed ID: 33553071
[TBL] [Abstract][Full Text] [Related]
19. A Review of Advances in Hematopoietic Stem Cell Mobilization and the Potential Role of Notch2 Blockade.
Albakri M; Tashkandi H; Zhou L
Cell Transplant; 2020; 29():963689720947146. PubMed ID: 32749152
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
